Titan Pharmaceuticals
TTNP
#10898
Rank
โ‚น0.58 B
Marketcap
โ‚น438.87
Share price
-3.76%
Change (1 day)
26.44%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น417.93. In 2023 the company made an earnings per share (EPS) of -โ‚น705.43 an increase over its 2022 EPS that were of -โ‚น1,446.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น705.43-51.22%
2022-โ‚น1,446-15.61%
2021-โ‚น1,714-81.37%
2020-โ‚น9,196-77.52%
2019-โ‚น40,917-56.32%
2018-โ‚น93,678-59.51%
2017-โ‚น2,31,384-371.81%
2016โ‚น85,127-144.35%
2015-โ‚น1,91,925300%
2014-โ‚น47,981-121.54%
2013โ‚น2,22,770-151.38%
2012-โ‚น4,33,545-11.54%
2011-โ‚น4,90,094188.89%
2010-โ‚น1,69,648-10%
2009-โ‚น1,88,498
2007-โ‚น7,72,841-2.38%
2006-โ‚น7,91,690-39.13%
2005-โ‚น13,00,634-16.87%
2004-โ‚น15,64,531-22.43%
2003-โ‚น20,16,9254.9%
2002-โ‚น19,22,67661.9%
2001-โ‚น11,87,535-13.7%
2000-โ‚น13,76,03365.01%
1999-โ‚น8,33,922-35.87%
1998-โ‚น13,00,412-1824.71%
1997โ‚น75,399-102.4%
1996-โ‚น31,47,911

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น831.54-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น668.30-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น385.56-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น87.58-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.85-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น405.55-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA